成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

ChemicalBook >> journal list >> Current medicinal chemistry >>article
Current medicinal chemistry

Current medicinal chemistry

IF: 3.5
Download PDF

Voglibose (Basen, AO-128), one of the most important alpha-glucosidase inhibitors.

Published:1 January 2006 DOI: 10.2174/092986706789803035 PMID: 16457643
Xiaolong Chen, Yuguo Zheng, Yinchu Shen

Abstract

The number of people with diabetes is expected to rise from the current estimated 150 million to 220 million in 2010 and 300 million in 2025, and 90% is Type 2 diabetes or non-insulin dependent diabetes mellitus (NIDDM). Voglibose, one of the most important alpha-glucosidase inhibitors, delays the digestion and absorption of carbohydrates, thereby inhibiting postprandial hyperglycemia and hyperinsulinemia, and is the aid in the treatment of diabetes. In this paper, properties and the preparation of voglibose are reviewed.

Substances (3)

Related products
Procduct Name CAS Molecular Formula Supplier Price
Voglibose 83480-29-9 C10H21NO7 538 suppliers $8.00-$1732.50
voglibose 1384518-63-1 C7H12O6 5 suppliers Inquiry
AO 128 112653-29-9 C10H21NO7 1 suppliers Inquiry

Similar articles

IF:2.5

Efficacy of voglibose in type 2 diabetes.

Expert Opinion on Pharmacotherapy Kohei Kaku,etc Published: 1 June 2014
IF:2.6

A spectrophotometric assay for the cyclization activity of cyclomaltohexaose (alpha-cyclodextrin) glucanotransferase.

Analytical biochemistry A Lejeune, K Sakaguchi,etc Published: 15 August 1989
IF:5.2

Pharmacological and biological effects of alpha-bisabolol: An updated review of the molecular mechanisms

Life sciences Elham Ramazani , Maryam Akaberi ,etc Published: 1 September 2022